CARE 17.15   -0.100 -0.60% Updated: 04-19-2017 $CARE

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
91
CARE 17.15   -0.100 -0.60% Updated: 04-19-2017 $CARE
Last Trade: 4/19/2017 9:56:00 AM
Last 17.15   -0.100 -0.60%
Open 17.15
Previous Close 17.25
Day High / Low 17.25 / 17.15
Year High / Low 9.25 / 7.15
Volume 21,095
Projected Volume 21095 (67%)
# of Trades / Projected 9 / 9
Dividend / Yield 0.40 / 3.25%
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle NEUTRAL
Volatility Today MEDIUM
Volatility Yesterday HIGH
Price Relativity
From 40 Day High 99%
From 80 Day High 99%
From 150 Day High 99%
From 40 Day Low 113%
From 80 Day Low 132%
From 150 Day Low 143%
Pivot Analysis
Price Pivot $ 17.15
Day Resistance 1 $ 17.15
Day Support 1 $ 17.15
Day Resistance 2 $ 17.15
Day Support 2 $ 17.15
Consolidations
Short Term YES
Medium Term NO
Long Term NO
Volume Indicators
20 Day Avg Vol 31,452
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 33,337
Today / 150 Day Avg Vol ABOVE
Abnormal Volume NO
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bullish
100 Day Trend bullish
Stochastics neutral
RSI neutral
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today MEDIUM
Volatility Index Yesterday HIGH
10 Day Volatility DECREASING
20 Day Volatility INCREASING
40 Day Volatility INCREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Huawei Introduces Innovative Wearables for Enhanced Connectivity

Updated Category News Views 293

Huawei Unveils Next-Generation Wearables and Tablets At a much-anticipated event, Huawei Consumer Business Group (CBG) revealed a thrilling array of new products. This launch showcased a strong emphasis on trendy wearables and sophisticated tablets, highlighting the brand's dedication to innovation and a user-friendly design. Chic Wearables for Style and Utility Among the...

Continue Reading
Investigating Barnes & Noble Education: Shareholder Rights Explained

Updated Category News Views 155

Understanding the Investigation of Barnes & Noble Education In a proactive move for investors, the law firm Bragar Eagel & Squire, P.C. is currently investigating Barnes & Noble Education, Inc. (BNED). This investigation aims to determine whether the company potentially breached federal securities laws or engaged in unlawful business practices that could lead to...

Continue Reading
Bailey Kennedy Achieves Landmark Legal Win for Talisman Group

Updated Category News Views 171

Bailey Kennedy Achieves Legal Victory for Talisman Group Judge Rules LNW Violated Talisman's Distribution Agreement by Marketing Competing Game In a significant legal development, Bailey Kennedy, LLP has successfully represented The Talisman Group, LLC, the innovative minds behind EZ Baccarat. The firm has recently triumphed in a legal dispute against LNW Gaming, Inc.,...

Continue Reading
Join the Class Action Lawsuit Against Ardelyx, Inc. Now

Updated Category News Views 49

Join the Class Action Lawsuit Against Ardelyx, Inc. Attention Ardelyx, Inc. investors! There's an important class action lawsuit underway, and this is your opportunity to get involved. Bronstein, Gewirtz & Grossman, LLC, a respected law firm known for its dedication to investor advocacy, has announced a class action case involving Ardelyx, Inc. (NASDAQ: ARDX) and certain...

Continue Reading
Aileron Therapeutics Unveils Q3 2024 Financial Performance

Updated Category News Views 97

Aileron Therapeutics Reports Impressive Q3 2024 Financial Results Aileron Therapeutics, Inc. (NASDAQ: ALRN), a biopharmaceutical company committed to developing innovative medicines for orphan pulmonary diseases, has recently showcased significant progress with their third-quarter financial results. This quarter has been marked by promising advancements in clinical trials...

Continue Reading